| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Wadley Research Institute and Blood Bank and The Graduate Research Institute of Baylor University, Dallas, Texas
Two L-asparaginase components were isolated from Escherichia coli by diethylaminoethyl cellulose column chromatography. The early emerging component (Peak I L-asparaginase), capable of causing complete regression of the Gardner 6C3HED lymphosarcoma, exhibited optimum activity at pH 7.58.6 and was stable on prolonged incubation with C3H mouse serum or peritoneal ascitic fluid. In contrast, the Peak II L-asparaginase component exhibited optimum activity at about pH 8.5, was significantly inactivated on incubation with the mouse humoral fluids, and lacked tumor-inhibitory activity. A number of factors which may influence the therapeutic usefulness of enzymes are presented.
1 This publication was made possible through the support of the Leukemia Society, Inc.
This article has been cited by other articles:
![]() |
G. E. Jones and R. K. Mortimer L-Asparaginase-Deficient Mutants of Yeast Science, January 9, 1970; 167(3915): 181 - 182. [Abstract] [PDF] |
||||
![]() |
B. Horowitz, B. K. Madras, A. Meister, L. J. Old, E. A. Boyse, and E. Stockert Asparagine Synthetase Activity of Mouse Leukemias Science, May 3, 1968; 160(3827): 533 - 535. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |